April 6th 2024
New data from a phase 3b trial presented at ACC.24 underlines the potential of inclisiran in reducing LDL-C levels among patients with ASCVD.
Viet Le, PA-C: Value of Disproportionate CAC vs Total CAC for Predicting MACE
March 10th 2023New research from Intermountain Healthcare presented at ACC 2023 examines the prognostic value of disproportionate CAC scores for 1 or more vessels relative to the value of total CAC score for predicting major adverse cardiovascular events.
Poor Sleep Health Linked to Subclinical Atherosclerosis, Increased Coronary Calcium Burden
February 15th 2023An analysis of actigraphy data obtained from the MESA Sleep Ancillary Study indicates irregularities in sleep patterns, particularly in duration and timing of sleep, were linked to increased markers of subclinical atherosclerosis, including increased coronary artery calcium burden.
Patients with Celiac Disease Had Higher CVD Risk, Despite Lower Risk Factor Prevalence
January 31st 2023An analysis of the UK Biobank suggests individuals with celiac disease had an incidence rate of 9.0 CVD cases per 1000 person years compared with 7.4 per 1000 person years in people with no celiac disease.
LITE Trial: Low-Intensity Walking Provides Little to No Benefit for PAD Patients
April 8th 2021Results of a 305-patient trial indicate ischemic leg pain could serve as a threshold for whether or not a patient with peripheral artery disease will see a meaningful improvement in walking score from their walking routine.
Diabetes, Insulin Resistance Help Predict Premature Coronary Heart Disease in Women
January 23rd 2021An analysis of data and blood samples from more than 28k women provides insight into the predictive value of more than 50 biomarkers for predicting risk of premature coronary heart disease in aging women.
Study Finds Hispanic, Latino Populations Underuse Cardiovascular Medication
August 5th 2020Among Hispanic and Latino patients with peripheral artery disease 31% reported use of antiplatelet therapy, 26% reported use of lipid-lowering therapy, and 57% reported use of antihypertensive therapy in a new study.